Literature DB >> 19827099

Paracellular porosity and pore size of the human intestinal epithelium in tissue and cell culture models.

Johanna Linnankoski1, Johanna Mäkelä, Joni Palmgren, Timo Mauriala, Charlotta Vedin, Anna-Lena Ungell, Lucia Lazorova, Per Artursson, Arto Urtti, Marjo Yliperttula.   

Abstract

The paracellular space defines the passive permeation of hydrophilic compounds in epithelia. The goal of this study was to characterise the paracellular permeation pathway in the human intestinal wall and differentiated epithelial cell models (MDCKII, Caco-2 and 2/4/A1). The permeabilities of hydrophilic polyethylene glycols (PEG) were investigated in diffusion chambers, and mass spectrometry was used to obtain accurate concentrations for each PEG molecule. The paracellular porosity and the size of the pores in the membranes were estimated from the PEG permeability data using an effusion-based approach. The porosities were found to be low (fraction 10(-7)-10(-5) of the epithelial surface) in all investigated membranes. Two different pore sizes (radii 5-6 and >10 A) were detected in the human intestinal epithelium and the Caco-2 and MDCKII cells, while only one (about 15 A) in the 2/4/A1 monolayer. The paracellular porosities of the human small intestine and 2/4/A1 monolayers were larger (>10(-7)) than that of the MDCKII and Caco-2 cells (<10(-7)). We report for the first time the quantitative values describing both porosity and pore size of the paracellular space in the human intestine. The cell models deviate from the small intestine either with respect to porosity (Caco-2, MDCKII) or pore size distribution (2/4/A1). 2009 Wiley-Liss, Inc. and the American Pharmacists Association

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19827099     DOI: 10.1002/jps.21961

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  22 in total

Review 1.  Coexistence of passive and carrier-mediated processes in drug transport.

Authors:  Kiyohiko Sugano; Manfred Kansy; Per Artursson; Alex Avdeef; Stefanie Bendels; Li Di; Gerhard F Ecker; Bernard Faller; Holger Fischer; Grégori Gerebtzoff; Hans Lennernaes; Frank Senner
Journal:  Nat Rev Drug Discov       Date:  2010-08       Impact factor: 84.694

Review 2.  Bile acid transporter-mediated oral drug delivery.

Authors:  Feiyang Deng; You Han Bae
Journal:  J Control Release       Date:  2020-07-22       Impact factor: 9.776

Review 3.  Safety concerns over the use of intestinal permeation enhancers: A mini-review.

Authors:  Fiona McCartney; John P Gleeson; David J Brayden
Journal:  Tissue Barriers       Date:  2016-04-12

4.  Shiga toxins induce autophagic cell death in intestinal epithelial cells via the endoplasmic reticulum stress pathway.

Authors:  Bin Tang; Qian Li; Xiu-hua Zhao; Hai-guang Wang; Na Li; Yao Fang; Kun Wang; Yin-ping Jia; Pan Zhu; Jiang Gu; Jing-xin Li; Yong-jun Jiao; Wen-de Tong; Marissa Wang; Quan-ming Zou; Feng-cai Zhu; Xu-hu Mao
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

5.  Drug discovery and regulatory considerations for improving in silico and in vitro predictions that use Caco-2 as a surrogate for human intestinal permeability measurements.

Authors:  Caroline A Larregieu; Leslie Z Benet
Journal:  AAPS J       Date:  2013-01-24       Impact factor: 4.009

Review 6.  Lessons learned from the clinical development of oral peptides.

Authors:  Morten Asser Karsdal; Bente Juul Riis; Nozer Mehta; William Stern; Ehud Arbit; Claus Christiansen; Kim Henriksen
Journal:  Br J Clin Pharmacol       Date:  2015-05       Impact factor: 4.335

Review 7.  Engineering in vitro immune-competent tissue models for testing and evaluation of therapeutics.

Authors:  Jennifer H Hammel; Jonathan M Zatorski; Sophie R Cook; Rebecca R Pompano; Jennifer M Munson
Journal:  Adv Drug Deliv Rev       Date:  2022-01-11       Impact factor: 15.470

8.  Leakiness and size exclusion of paracellular channels in cultured epithelial cell monolayers-interlaboratory comparison.

Authors:  Alex Avdeef
Journal:  Pharm Res       Date:  2010-03       Impact factor: 4.200

9.  Population pharmacokinetic modeling and deconvolution of enantioselective absorption of eflornithine in the rat.

Authors:  Carl-Christer Johansson; Peter Gennemark; Per Artursson; Angela Äbelö; Michael Ashton; Rasmus Jansson-Löfmark
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-01-10       Impact factor: 2.745

10.  Structural features determining the intestinal epithelial permeability and efflux of novel HIV-1 protease inhibitors.

Authors:  Lucia Lazorova; Ina Hubatsch; Jenny K Ekegren; Johan Gising; Daisuke Nakai; Noha M Zaki; Christel A S Bergström; Ulf Norinder; Mats Larhed; Per Artursson
Journal:  J Pharm Sci       Date:  2011-04-13       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.